Home

CHRISTIAN S SCHADE

CIK 1214496 · Chairman & CEO · last filed 2026-05-11

CHRISTIAN S SCHADE is a Chairman & CEO who has filed 47 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for IART, was dated May 11, 2026. Across all open-market trades the lifetime net is −$2.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$6.00M

Companies

5

Total Filings

47

Lifetime Open-Market Net

-$2.43M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
IART Director 90,034 $17.21 $1.55M -$2.54M 25 2026-05-11
Omega Therapeutics, Inc. (OMGA) Delisted Director — $0.14 — $0 4 2024-06-21
APRE Chairman & CEO 13,212 $0.62 $8.2K $114.1K 8 2022-08-01
NRG Exec VP & Chief Financial Ofc 34,916 $127.21 $4.44M $0 2 2011-03-30
MEDX SVP & CFO 0 $36.03 $0 $0 5 2009-08-31

Recent Filings

47 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-05-11 IART Grant (A) — $0 EDGAR
2025-05-13 IART Grant (A) +26,531 $0 EDGAR
2024-06-21 Omega Therapeutics, Inc. (OMGA) Delisted Grant (A) — $0 EDGAR
2024-05-13 IART Grant (A) +8,696 $0 EDGAR
2024-02-09 Omega Therapeutics, Inc. (OMGA) Delisted Grant (A) — $0 EDGAR
2024-02-09 Omega Therapeutics, Inc. (OMGA) Delisted Grant (A) — $0 EDGAR
2023-07-12 Omega Therapeutics, Inc. (OMGA) Delisted Grant (A) — $0 EDGAR
2023-05-16 IART Grant (A) +4,486 $0 EDGAR
2022-08-01 APRE Grant (A) +32,400 $0 EDGAR
2022-06-07 APRE Tax (F) −65,770 -$52.9K EDGAR
Showing 1–10 of 47
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.